Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions

被引：145

作者：

Adams J.D. ^{[1
]}

Wang R. ^{[2
]}

Yang J. ^{[3
]}

Lien E.J. ^{[2
]}

机构：

[1] Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of Southern California, Los Angeles, CA 90089-9121

[2] Department of Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90089-9121

[3] Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Southern California, Los Angeles

来源：

Chinese Medicine | / 1卷 / 1期

关键词：

Stroke Patient; Naloxone; Total Effective Rate; Salvianolic Acid; Carthamus Tinctorius;

D O I：

10.1186/1749-8546-1-3

中图分类号：

学科分类号：

摘要：

Salvia miltiorrhiza (Labiatae, Laminaceae), danshen, is an annual sage mainly found in China and neighboring countries. The crude drug (dried root) and its preparations are currently used in China to treat patients suffering from heart attack, angina pectoris, stroke and some other conditions. The use of S. miltiorrhiza has been increasing in the management of stroke. Pharmacological examinations showed that the plant and its active ingredients, tanshinones and salvianolic acids, have anticoagulant, vasodilatory, increased blood flow, anti-inflammatory, free radical scavenging, mitochondrial protective and other activities. This review discusses the pharmacology, medicinal chemistry and clinical studies published, especially in China, for danshen and tanshinone preparations. Clinical examinations are evaluated in terms of S. miltiorrhiza preparation, dose, double blinding, control, clinical assessments of outcomes and other parameters. Meta-analyses of S. miltiorrhiza are also discussed. © 2006 Adams et al; licensee BioMed Central Ltd.

引用

共 86 条

[21]

Kim S.Y., Moon T.C., Chang H.W., Son K.H., Kang S.S., Kim H.P., Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses, Phytother Res, 16, pp. 616-620, (2002)

[22]

Kang B.Y., Chung S.W., Kim S.H., Ryu S.Y., Kim T.S., Inhibition of interleukin-12 and interferon gamma production in immune cells by tanshinones from Salvia miltiorrhiza, Immunopharmacol, 49, pp. 355-361, (2000)

[23]

Li X.H., Tang R.Y., Relationship between inhibitory action of tanshinone on neutrophil function and its prophylactic effects on myocardial infarction (Chinese), Zhongguo Yaoli Xuebao, 12, pp. 269-272, (1991)

[24]

Sun J., Huang S.H., Tan B.K., Whiteman M., Zhu Y.C., Wu Y.J., Ng Y., Duan W., Zhu Y.Z., Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction, Life Sci, 76, pp. 2849-2860, (2005)

[25]

Ji X.Y., Tan B.K.H., Zhu Y.C., Linz W., Zhu Y.Z., Comparison of cardioprotective effects using ramipril and danshen for the treatment of acute myocardial infarction in rats, Life Sci, 73, pp. 1413-1426, (2003)

[26]

Zhou G., Jiang W., Zhao Y., Ma G., Xin W., Yin J., Zhao B., Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria, Biochem Pharmacol, 65, pp. 51-57, (2003)

[27]

Cao E.H., Liu X.Q., Wang J.J., Xu N.F., Effect of natural antioxidant tanshinone IIA on DNA damage by lipid peroxidation in liver cells, Free Rad Biol Med, 20, pp. 801-806, (1996)

[28]

Wang A.M., Sha S.H., Lesniak W., Schacht J., Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside induced free radical formation in vitro and ototoxicity in vivo, Antimicrob Agents Chemother, 47, pp. 1836-1841, (2003)

[29]

Ai W.B., Chen Y.H., Yang Q.J., Clinical observation on effect of xuesaitong injection as auxiliary treatment of severe craniocerebral injury (Chinese), Chin J Integ Trad West Med, 24, pp. 213-215, (2004)

[30]

Leung A.W., Mo Z.X., Zheng Y.S., Reduction of cellular damage induced by cerebral ischemia in rats, Neurochem Res, 16, pp. 687-692, (1991)

← 1 2 3 4 5 6 7 8 9 →